Pune, India, March, 2019/MRFR Press Release/- Market Research Future has published a cooked research report on the Global Lidocaine Market.
Market Highlights
The global lidocaine market is expected to register a CAGR of 8.40 % during the forecast period and is anticipated to account for a market value of USD 1,476.09 million by 2021. Lidocaine is a local anesthetic and cardiac depressant which is used as an antiarrhythmic agent. The growing geriatric population, increasing application of lidocaine in several dental procedures, and rising incidence of dental caries and other periodontal diseases are expected to propel the growth of the global lidocaine market over the forecast period.
The rising adoption of the lidocaine formulations such as lidocaine ointment in various cosmetic procedures such as laser surgery, soft tissue augmentation, among others for pain relief is anticipated to fuel the market growth. Similarly, increasing disposable income in developing countries and increase in awareness of preventive healthcare among the population are anticipated to boost the market growth. On the other hand, strict regulatory policies may hamper the growth of the market during the assessment period.
Segment analysis
The global lidocaine market has been segmented into formulation, application, and distribution channel. On the basis of formulation, the lidocaine market can be segmented into injections, creams, ointments, gels, aerosol liquids, and others. Based on application, the global lidocaine market has been segmented into dentistry, cardiac arrhythmia, epilepsy, cosmetics, and others. The lidocaine market on the basis of distribution channel has segmented into hospital pharmacies, retail pharmacies, and others. The hospital pharmacies segment is accounted for a market value of USD 596.76 million in 2017.Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/lidocaine-market-1308
Regional Analysis
Geographically, the Americas is expected to dominate the global lidocaine market. The market growth in the region is due to the growing number of surgeries, increasing R&D activities and rising demand for lidocaine formulations in dental and cosmetic procedures. Europe showed a significant amount of growth in the market owing to the increasing adoption of lidocaine injections as local anesthetics during the surgeries and huge patient population. As per MRFR analysis, the UK accounted for a market share of 25.8% in the Europe lidocaine market in 2017. Asia-Pacific is anticipated to be the fastest growing region in the market and expected to grow with a CAGR of 9.21% over the forecasted period. The market growth in the region is due to the rising number of cosmetic procedures, dental procedures, and plastic surgeries. On the other hand, the Middle East & Africa has the least share of the global lidocaine market due to the low disposable income and poorly developed healthcare infrastructure, especially in the African region.
Key Findings of the Study
- Global lidocaine market is projected to reach USD 1,476.09 million by 2021 with 8.40% CAGR during the review period of 2018 to 2021
- Americas accounted for the largest share in the region due to the high adoption rate of lidocaine in dental procedures.
- The hospital pharmacies segment is accounted for the largest share, holding a market value of USD 596.76 million in 2017.
- Some of the players operating in the lidocaine market are AstraZeneca, Glenmark Pharmaceuticals Limited, Teligent, Septodont Holding, and Amneal Pharmaceuticals LLC among others.
This research report provides insights, on various levels of analysis such as industry analysis, market share analysis, leading market players, and their profiles. This report also helps in studying the target segments by providing views on emerging and high-growth segments and market conclusion. Together the market data comprises and discusses basic assessments on the competitive scenarios and strategies of the global lidocaine market, including the high-growth regions and their political, economic, and technological environments. Furthermore, the project report also provides views over historical market values as well as, pricing and cost analysis of the same.
Related Reports
- Vitamin K2 Market Research Report: by Product Type (MK-7, MK-4, Others), by Source (Natural, Synthetic), by Form (Oil, Powder, Others), by Application (Nutraceutical & Food, Pharmaceutical), and Region - Global Forecast till 2023
- Immunotherapy Drugs market research report, by type (Implant reconstruction, Autologous or "flap" reconstruction), product type (silicone, saline) end user (hospitals & clinics, ambulatory surgical centers) – Global forecast till 2023
- Global Alopecia Drugs Market Information, by alopecia type (alopecia areata, alopecia totalis, and alopecia universalis), by product type (tropical, oral and others), by end user (hospitals and clinics, saloons and home care) - Forecast till 2022
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Base Year | 2019 |
Companies Covered | 15 |
Pages | 117 |
Certified Global Research Member
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.